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Cystic fibrosis (CF) is characterised by the absence of CFTR function resulting in a reduced Cl− secretion and an increase in Na+
absorption. This Na+ hyperabsorption is mediated by the human amiloride-sensitive epithelial sodium channel (ENaC), but the underlying
mechanisms are still unknown. After demonstrating functional differences of the Na+ absorption in CF and non-CF epithelia in Ussing
chamber experiments with human primary cultures, we compared ENaC sequences from CF and non-CF human nasal tissue (hnENaC),
investigated the mRNA transcription levels via real-time PCR and studied the protein expression in Western blot analyses. We found no
differences in the sequences of CF and non-CF hnENaC, but identified some polymorphisms. The real-time experiments revealed an
enhanced mRNA amount of all three hnENaC subunits in CF tissue. By comparing the two groups on the protein level, we observed
differences in the abundance of the Na+ channel. While the α- and β-hnENaC protein amount was increased in CF tissue the γ-hnENaC was
decreased. We conclude that the Na+ hyperabsorption in CF is not caused by mutations in hnENaC, but by an increase in the transcription of
the hnENaC subunits. This could be induced by a disturbed regulation of the channel in CF.
© 2007 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: ENaC; Cystic fibrosis; Na+ hyperabsorption; Human nasal epithelia; Expression level; Real-time PCR1. Introduction
Cystic fibrosis (CF) is a genetic disorder caused by a
defect in the cystic fibrosis transmembrane conductance
regulator (CFTR) gene, which encodes a chloride channel in
epithelial cells. This defect results in ion transport abnor-
malities, which are characterised by a reduced Cl− secretion
and a markedly increased Na+ absorption [1–3] mediated by
the amiloride-sensitive epithelial sodium channel (ENaC).
Substantial progress has been made to understand the
function and regulation of CFTR. But since several years
the Na+ transport defect in CF patients due to ENaC has
become focus of many studies. This channel is located in the
apical membrane of epithelial cells and mediates the first step
of sodium absorption in various organs, e.g. kidney, colon
and lung [4]. ENaC is composed of three homologous sub-
units named α, β and γ, which together form the functional⁎ Corresponding author. Tel.: +49 251 83 21782; fax: +49 251 83 21785.
E-mail address: wmw@uni-muenster.de (W.-M. Weber).
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doi:10.1016/j.jcf.2007.07.012channels [5,6]. Additionally, a δ-subunit of ENaC was
cloned from human brain [7]. The stoichiometry of ENaC is
still a matter of discussion. Most groups propose a tet-
rameric structure [8,9], while others suggest that ENaC is
formed by nine subunits [10,11]. However, the relation
between structure and function has not been well defined so
far. As a possible explanation for the excessive Na+ absorp-
tion via ENaC a direct interaction with CFTR was pos-
tulated, which is known to be an important regulator of
other proteins [12–15]. In the case of CF CFTR is not
effectively inserted into the plasma membrane and the reg-
ulatory effect is no longer provided. Recently, it was shown
that such a direct inhibitory effect of CFTR on ENaC does
probably not exist [16].
The importance of human ENaC in Na+ and fluid
homeostasis is emphasised by the recent findings that
mutations in the subunits are associated with different
diseases. It was shown that some non-classical CF patients,
who did not show any CFTR mutations, exhibited mutations
in the β-ENaC subunit, associated with abnormal function ofed by Elsevier B.V. All rights reserved.
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mutations in the β- and γ-ENaC subunits lead to e.g.
Liddle's syndrome [18,19] and pseudohypoaldosteronism
(PHA I) [20]. PHA I shares some symptoms with CF such as
elevated sweat electrolytes and Pseudomonas aeruginosa
infections in the lung [21,22]. As a matter of fact, changes in
the molecular structure of ENaC influence the function of the
protein.
Furthermore, variations in the channel expression level
may affect the Na+ transport in epithelial cells. Recently, it
was reported that an increase in β-ENaC expression in
murine airway tissue evokes symptoms typically observed in
CF lung disease [23]. Another hint for the involvement of
transcriptional ENaC regulation in CF is the fact that β-ENaC
mRNA is transiently increased in another murine model
infected with P. aeruginosa [24]. These observations show
that mutations in ENaC subunits and/or altered expression
cause diverse dysfunctions in Na+ absorption. So far, there is
no adequate explanation for the functional upregulation of
ENaC in CF epithelia or the mechanisms leading to this Na+
hyperabsorption. However, all available data taken together,
an upregulation of ENaC associated with an increased Na+
absorption in CF epithelia can be postulated. To demonstrate
the functional differences of the Na+ absorption in CF and
non-CF epithelia we performed Ussing chamber experiments
with primary cultures of human nasal epithelia cells grown on
permeable filters. These measurements confirm and extend
previous findings of our group [3,25,26] that the amiloride-
sensitive Na+ absorption via ENaC in CF epithelia is
significantly increased compared with non-CF epithelia in
vitro. The underlying molecular mechanisms of this ENaC
disorder are not known but it is possible that the differences in
Na+ transport in CF and non-CF tissue are due to structural
variations of the channel. Therefore, we cloned and
sequenced all three human nasal ENaC (hnENaC) subunits
from CF and non-CF specimen and compared the nucleotide
sequences. Since we identified no sequence abnormalities
between CF and non-CF hnENaC, which might lead to an
increased ENaC activity, we studied the mRNA expression of
ENaC via quantitative real-time PCR (qRT-PCR). We
observed an increase in mRNA expression levels of all
three hnENaC subunits in CF tissue. Additionally, we deter-
mined the presence and abundance of hnENaC at the protein
level and detected considerable differences in the expres-
sion pattern between CF and non-CF tissue. While α- and β-
ENaC were increased, γ-ENaC protein expression was de-
creased in CF epithelia compared to non-CF tissue.
2. Materials and methods
2.1. Patients
We obtained nasal specimens from CF and non-CF
patients undergoing nasal surgery. The samples were nasal
polyps of patients suffering from chronic sinusitis. The study
was approved by the committees for human studies of theUniversity of Muenster (Ethik Kommission Muenster) and
the University of Giessen (Ethik Kommission der Justus-
Liebig-Universitaet Giessen). All patients gave informed
consent.
For cloning and qRT-PCR experiments we combined four
non-CF samples. To get precise values of the different
individual CF patients these samples were not combined and
used for relative comparison to the non-CF samples. For
qRT-PCR experiments we analysed five patients homozy-
gous for ΔF508 and one with a compound heterozygoty
for ΔF508/R553X (also used for molecular cloning). For
Western blot experiments we used four non-CF and two CF
samples. All CF patients showed the full-blown clinical
picture of cystic fibrosis.
2.2. Cell culture
Primary cell culture of the human nasal epithelium was
performed as described before [27]. The CF and non-CF nasal
epithelial cells were isolated by enzymatic digestion for 24–
48 h and afterwards seeded on permeable collagen filters
with a diameter of 14 mm (Cellagen TM dics CD 24, ICN
Biomedicals, Costa Mesa, USA). The cells were cultured with
serum-free F-12 Nutrient Mixture (Ham) (Invitrogen/Gibco,
Karlsruhe, Germany) supplementedwith the following agents:
insulin (2 μg/ml) (Invitrogen/Gibco), epidermal growth factor
(13 ng/ml) (Sigma, Deisenhofen, Germany), endothelial cell
growth supplement (7.5 μg/ml) (Becton Dickinson GmbH,
Heidelberg, Germany), triiodo-thyronine (3 nM) (Sigma),
hydrocortisone (100 nM) (Sigma), gentamycin (10 μg/ml)
(Biochrom AG, Berlin, Germany), penicillin/streptomycin
(100 U/ml) (Invitrogen/Gibco), L-glutamin (2 mM) (Invitro-
gen/Gibco) and transferrin (4 μg/ml) (Invitrogen/Gibco).
Previously, it was shown that these supplements had no effect
on the electrical parameters of the human nasal epithelium
[25]. Cells were incubated in 95% air and 5%CO2 at 37 °C. 7–
9 days after seeding the cells on the membrane, we normally
obtained confluent monolayers and proceeded with Ussing
chamber measurements.
2.3. Transepithelial measurements
After reaching confluence, the nasal epithelial cells were
mounted in modified Ussing chambers designed by Prof.
Willy Van Driessche (KU Leuven, Belgium). The two
compartments of the Ussing chamber were continuously
perfused with cell culture Ringer at 37 °C. Voltage and
current electrodes (AgCl wires) were used and were
electrically connected to the chamber by KCl-agar bridges.
The current electrodes held the transepithelial potential (Vt),
which is established by an active transport of ions to zero.
The required current of compensation, called short circuit
current (Isc), depends on changes in conductance of the
epithelium, which is generated by perfusion of different
solutions. Isc was continuously monitored using the
computer program ImpDsp1.4 (Prof. Willy Van Driessche).
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parameters were normalised to an area of 1 cm2.
2.4. Solutions
Cell culture Ringer was composed as follows: 130 mM
NaCl, 5 mMKCl, 1 mMCaCl2, 2 mMMgCl2, 5 mM glucose,
10 mM HEPES. In the Na+-free solution used, NaCl was
replaced by an equivalent amount of TMACl (tetramethy-
lammonium chloride). For investigation of the amiloride-
sensitive currents through ENaC the apical compartment of
the Ussing chamber was perfused with amiloride (100 μM) in
cell culture Ringer.
2.5. Extraction of RNA
Total RNA was extracted from human CF and non-CF
nasal polyps following the standard protocol of RNeasy Mini
kit plus (Qiagen, Hilden, Germany). In this procedure the
genomic DNA contamination was effectively removed with
a gDNA Eliminator spin column, so that additional DNase
digestion was not necessary. Afterwards, the RNA was
eluted in 30 μl RNase-free water.
The concentration of RNAwas determined by absorbance
measurement at 260 nm (A260) in a spectrophotometer using
UV cuvettes. The integrity and size distribution of total RNA
was analysed via denaturing agarose gel electrophoresis and
ethidium bromide staining. To check the RNA quality 1.5 μg
total RNA was loaded per lane.
2.6. cDNA synthesis
Total RNA (1 μg) was used to generate first-strand cDNA
by using the SuperScript II reverse transcriptase kit
(Invitrogen) and oligo (dT) primers. Finally, cDNA was
diluted 1:10 prior to use in qRT-PCR.
2.7. Molecular cloning of CF and non-CF α-, β-, γ-hnENaC
cDNA
After PCR amplification with specific oligonucleotide
primers for the three subunits according to the published
sequences of human ENaC (http://www.ncbi.nih.gov), all
expected distinct bands were excised using the QIAquick
Gel Extraction kit (Qiagen) and cloned into the pCR®II-
TOPO TA vector (Invitrogen). Since no full-length clones
for the α-hnENaC and γ-hnENaC could be amplified, the 3′
end of the α-hnENaC cDNA was obtained applying the
protocol for rapid amplification of cDNA ends (RACE)
following the suppliers directions (Invitrogen). 5′ RACE
assays were carried out for the α- and γ-hnENaC subunits
with a series of nested oligonucleotide primers using the 5′
RACE kit (Invitrogen). Products of those PCR reactions
were also cloned in the pCR®II-TOPO TA vector. Full-
length β-hnENaC was generated using two specific primers
overlapping the untranslated region and the coding se-quence (5′-GCC CGA GCA GGT GCC ACTATG C-3′and
5′-GGT GGA CAG GGG CAG GGT TAG ATG-3′). The
nucleotide sequences of non-CF α-, β-, γ-hnENaC cDNA
were submitted to GenBank, accession numbers DQ402522
(α-hnENaC), DQ402523 (β-hnENaC) and DQ402524 (γ-
hnENaC).
2.8. Sequence data analysis
For cDNA sequence analysis and molecular weight
prediction of the amino acid sequences we used the tools
provided by the ExPasy Molecular Biology Server of the
Swiss Institute of Bioinformatics (http://www.expasy.ch)
and the National Centre for Biotechnology Information
(http://www.ncbi.nlm.nih.gov). All clones were commercial-
ly sequenced by GENterprise (GENterprise GmbH, Mainz,
Germany). The complete α-, β- and γ-hnENaC amino acid
sequences of CF and non-CF tissue were added to a multi-
sequence alignment by using GENEDOC 2.6.
2.9. Quantitative real-time PCR with SYBR® Green I
For qRT-PCR experiments cDNA was generated as
described before. We combined the cDNA from four non-
CF patients to avoid statistical spreading in this control
tissue. The oligonucleotide primers for qRT-PCR were
selected to bind specifically to human cDNA and created
spanning exon/exon boundaries to prevent amplification of
genomic DNA. All selected specific primers (Table 1)
produce a PCR-fragment in the range of 100 bp.
For qRT-PCR we used the iQ5 Real-Time PCR Detection
System (Biorad, Munich, Germany) and the iQ™ SYBR®
Green Supermix (Biorad). Optimal reaction conditions were
obtained with 12.5 μl 2x iQ™ SYBR® Green Supermix
(100 mM KCl, 40 mM Tris HCl, pH 8.4, 0.4 mM of each
dNTP (dATP, dCTP, dGTP and dTTP), iTaq DNA polymer-
ase 50 units/ml, 6 mM MgCl2, SYBR® Green I, 20 nM
fluorescein and stabilizers), 5 μM of each primer and 4 μl of
the diluted cDNA in a total volume of 25 μl. Amplifications
were performed starting with a 2 min template denaturation
step at 95 °C followed by 45 cycles of denaturation at 95 °C
for 10 s and a combined primer annealing/extension at the
gene specific primer temperature (60 °C) for 30 s. At the end
of each PCR a melting curve with increasing temperature
from 60 °C to 95 °C in steps of 3 °C min−1 was generated.
The fluorescence increase was automatically measured every
10 s to detect fluorescence-alteration and to confirm the
specificity of the amplification. To determine the primer-
efficiency a 1:5 dilution series was performed with non-CF
cDNA as template. All samples were amplified in triplicate
and the CT values were obtained for further calculations.
2.10. Real-time PCR data analysis
The data were analysed using the iCycler iQ Software
Version 3.1 (Biorad). This software determines the threshold
Table 1
Nucleotide sequences of primers used in quantitative real-time RT-PCR
Targets Sequences 5´-3´ Amplicon
length (bp)
Tm
(° C)
α-hnENaC CCTCTGTCACGATGGTCACCCTCC 113 60
CTGAGCTCGTCTTTGACCTGCTG 60
β-hnENaC CCAATATCACCCTGAGCAGGAAGGG 112 60
CAATAACATCGTCTGGCTGCTCTCG 61
γ-hnENaC GAGCCCAGCCAACAGTATTGAGATG 93 59
CTCTGTTGTCTGCGTCATCGAGATC 60
h-GAP-DH CATCACCATCTTCCAGGAGCGAG 109 59
CACCACCATGGAGAAGGCTGGGG 60
h-β-Actin CCTGGAGAAGAGCTACGAGCTG 107 60
CCTTCCTTCCTGGGCATGGAGTC 59
h-PolRIIa CTTGTGTGATACCATGACCTGTCGTG 115 60
CCTTTGAGGAAACGGTGGACGTGC 60
Tm, melting temperature.
Fig. 1. Total short circuit current (Isc, light grey bars) and amiloride-sensitive
short circuit current mediated by ENaC (Isc(amilo), black bars) in non-CF
(nCF) and CF human nasal primary cultured cells. The number of
preparations is given in brackets. The results are different at a significance
level of pb0.001.
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during the exponential phase of the PCR. For the relative
quantification the obtained CT-values were normalised with
three housekeeping genes (HKG) as reference index. As
HKG we used a structure-related gene (human β-Actin), a
metabolism-related gene (human GAP-DH) and a transcrip-
tion-related gene (human PolRIIa). The normalisation was
reached by means of the REST©-Software (Relative Ex-
pression Software Tool V1.9.9©2005, Corbett Research Pty.
Ldt.). The used mathematical model is based on the PCR-
efficiency and the mean threshold cycle deviation [28,29].
2.11. Protein biochemistry
Membrane proteins from human nasal epithelium were
isolated using lysis buffer (1 mM Tris ,15 mMNaCl, 0.2 mM
EDTA, 2% Triton X-100) and a protease inhibitor cocktail
(10 mM Leupeptin, 1 mg/ml Trypsininhibitor, 25 μM Pefa-
block, 100 mM PMSF) was added to this detergent mixture.
It was shown that 2% Triton X-100 is sufficient to solve all
of the intracellular and cell surface pools of the sodium
channel ENaC [30]. The extracts were homogenised with a
Sonifier®ultrasonic cell disrupter (Branson, Danbury, USA)
and centrifuged for 30 min at 4,000 g at 4 °C to remove
insoluble material. The concentration of the proteins in the
supernatant was measured photometrically using the Brad-
ford test [31]. For the detection of the α- and β-ENaC
subunits 10 μg and for the γ-ENaC subunit 20 μg of total
membrane proteins were separated via SDS-PAGE (7.5%
acrylamide) and transferred to a PVDF membrane. Non-
specific binding sites were blocked for 2 h with 5% nonfat
dry milk in Tris-buffered saline/Tween (TBST: 10 mM Tris
HCl, pH 7.4; 140 mM NaCl; 0.3% Tween 20). The ENaC α-
and γ-subunit were detected with a rabbit anti α-ENaC and a
rabbit anti γ-ENaC antibody (Dianova, Hamburg, Ger-
many), respectively with a concentration of 1:2,500 dilut-
ed in 5% nonfat dry milk/TBSTovernight at 4 °C. The ENaC
β-subunit was detected with a rabbit anti β-ENaC antibody
(Santa Cruz, California, USA) with a concentration of 1:100
diluted in 1% nonfat dry milk/TBST overnight at 4 °C. Afterwashing in TBST the membrane was incubated for 1 h at
room temperature with the goat anti-rabbit IgGs conjugated
with alkaline phosphatase (Dianova) diluted 1:10,000 in 5%
nonfat dry milk/TBST for the α- and γ-subunit and with the
goat anti-rabbit IgGs conjugated with alkaline phosphatase
(Santa Cruz) diluted 1:10,000 in 1% nonfat dry milk/TBST
for the β-subunit. The membrane was washed again in TBST
and detection was carried out with NBT (nitroblue tetra-
zolium) and BCIP (5-bromo-4-chloro-3-indolyl phosphate).
2.12. Densitometric evaluation of Western blots
The transferred PVDF membranes were digitally scanned
and protein bands were semi-quantitatively analysed by
densitometry using ImageJ analysis software 1.36 [32]. We
calculated the areas of the detected bands from the CF and
non-CF samples. These values were given as x-fold alteration
according to the α-, β- and γ-hnENaC subunit abundance.
For demonstration the non-CF samples were set as control
and therefore, normalised to 1.0 (100%).
2.13. Statistics
Where applicable, data are expressed as arithmetic means±
SEM; n is the number of experiments. Statistical analysis was
made by the t-test where appropriate, and a significant dif-
ference was assumed at pb0.001.
3. Results
3.1. Transepithelial measurements
With electrophysiological measurements in modified
Ussing chambers we showed in vitro that the amiloride-
sensitive Na+ absorption via ENaC in human nasal CF
primary cultured cells was significantly increased compared
Fig. 2. mRNA expression data for all three hnENaC subunits of CF patients.
Data were acquired by real-time PCR and are shown as x-fold increase±
SEM of mRNA expression for each subunit and CF patient, respectively.
Relative mRNA expression of the combined non-CF population was
normalised to 1.0 (100%). α-hnENaC mRNA expression is marked by a
black column for CF specimen 1: 1.46-fold±0.17; for CF specimen 2: 2.5-
fold±0.28; for CF specimen 3: 2.23-fold±0.33; CF specimen 4: 1.25-fold±
0.12; for CF specimen 5: 1.20-fold±0.08; for CF specimen 6: 1.38-fold±
0.09. The β-hnENaC mRNA expression is displayed by a dark grey column
for CF specimen 1: 2.57-fold±0.09; for CF specimen 2: 1.86-fold±0.13; for
CF specimen 3: 5.96-fold±0.23; CF specimen 4: 2.51-fold±0.04; for CF
specimen 5: 2.34-fold±0.20; for CF specimen 6: 4.70-fold±0.51. The γ-
hnENaC mRNA expression is represented by a light grey column for CF
specimen 1: 6.07-fold±0.33; for CF specimen 2: 1.34-fold±0.03; for CF
specimen 3: 3.49-fold±0.31; CF specimen 4: 3.26-fold±0.32; for CF
specimen 5: 1.31-fold±0.08; for CF specimen 6: 4.99-fold±0.40.
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total transepithelial current (Isc) could be inhibited by amilo-
ride. This amiloride-sensitive current (Isc(amilo)) is mediated
by ENaC. Isc in CF epithelia was increased by∼40% (Fig. 1,
grey bars). However, Isc(amilo) mediated by ENaC was nearly
doubled in CF epithelia (Fig. 1, black bars). Interestingly,
almost the complete transepithelial current in CF epithelia
was mediated by ENaC while in non-CF epithelia around
half of total Isc was mediated by amiloride-insensitive Na
+
conductances, which are not identified so far.
3.2. Cloning of α-, β- and γ-hnENaC from CF and non-CF
epithelia
The quality of total RNAwas proven for each experimental
approach. The agarose gel showed the human 28 S and 18 S
rRNA bands that confirmed the correct ratio of 2:1 and no
contaminating DNA or RNA degradation products.
We cloned and sequenced all three hnENaC subunits from
CF and non-CF tissue and compared the amino acid
sequences in a multi-sequence alignment with each other.
We found no sequence differences between CF and non-CF
hnENaC. The general properties like the calculated molec-
ular weight and nucleotide sequence length (α-ENaC: 2010
bp; β-ENaC: 1923 bp; γ-ENaC: 1950 bp) are in agreement
with the previously published properties of hENaC (http://
www.ncbi.nlm.nih.gov). The sequences of the full-length
non-CF α-, β- and γ-hnENaC cDNA were submitted to
GenBank, those of CF α-, β- and γ-hnENaC are equal to the
non-CF sequences (100% homology).
Furthermore, we detected single nucleotide polymorph-
isms (SNP) within both sequences of CF and non-CF
hnENaC in comparison with already published sequences
(Table 2).
3.3. Quantitative real-time PCR
Quantitative real-time PCR was used to examine the RNA
transcription levels of CF and non-CF hnENaC subunits. The
different RNA transcription levels were determined via
relative quantification of the obtained CT values calculated
by the REST© software. The CT is defined as the number
of cycles needed for the fluorescence to reach a specif-Table 2
Single nucleotide polymorphisms in the α-, β- and γ-hnENaC subunits from
CF and non-CF tissue and appropriate references
α-ENaC Reference β-ENaC Reference γ-ENaC Reference
T663A [53,54] A314G [55] R178W
P502A
A614S
[53,55,56]
A336P [53,56]
F339S
A350T
Y369S
D375G
S458R
[55]ic threshold level of detection and is inversely correlated
with the amount of template nucleic acid present in the
reaction [33]. We compared the expression of the α-, β- and
γ-hnENaC subunits in the nasal epithelium of six CF-
patients relative to the expression of a combined compilation
of four non-CF patients normalised to 1.0 (Fig. 2). Although
the subunit composition slightly oscillated for every in-
dividual patient, we found that the amount of the α-, β- and
γ-hnENaC mRNA expression in human nasal CF tissue is
obviously increased compared to non-CF tissue. For a
descriptive demonstration of each measured CF specimen we
averaged the obtained data. We observed that the α-hnENaC
gene of the CF group showed a 1.7-fold increase in the
mRNA transcription level compared with the combined non-
CF group. The β-hnENaC mRNA expression in CF tissue is
even 3.3-fold enhanced on average compared with the
control group. Furthermore, we found an averaged 3.4-fold
increase in γ-hnENaC mRNA expression in CF tissue as
compared with non-CF tissue. The values of each individual
are partially increased. One CF patient (CF specimen 3)
revealed a 5.96-fold increased β-hnENaC subunit expres-
sion, while another CF patient (CF specimen 6) showed a
4.7-fold increase for this subunit. Insofar, these individual
values exceeded the average of 3.2-fold for the β-hnENaC
subunit nearly twice. We found a similar situation for
Fig. 3. (A) Western Blots of the three hnENaC subunits from CF and non-CF
tissue. Total membrane proteins from human nasal CF and non-CF tissue
were isolated using 2% Triton X-100 and separated on a 7.5% SDS-PAGE.
To identify ENaC we used specific anti-ENaC antibodies against the
subunits. We detected two specific bands of α-ENaC in the range of 66 and
55 kDa in the non-CF control and the CF tissue, respectively (A), one
specific band of β-ENaC in the range of 73 kDa (B) and a γ-ENaC specific
band in the range of 74 kDa (C).(B) Semi-quantitative protein expres-
sion of hnENaC in CF and non-CF tissue. Expression of hnENaC α-, β- and
γ-protein was studied in normal (non-CF) and CF nasal polyps by Western
blotting and quantified by densitometry using ImageJ 1.36. We found a 5±
1.6-fold increase of the α-hnENaC protein (n=5), a 3.5±0.6-fold increase of
the β-hnENaC (n=6) and a 4-fold (0.24±0.07) decrease of the γ-hnENaC
protein (n=5) in CF tissue compared with the non-CF tissue. Relative
protein expression of the non-CF hnENaC control protein was normalised to
1.0 (100%).
202 N. Bangel et al. / Journal of Cystic Fibrosis 7 (2008) 197–205samples of γ-hnENaC subunit: two CF patients showed
drastically enhanced amounts of the γ-hnENaC mRNA (CF
specimen 1: 6.07-fold; CF specimen 6: 4.99-fold) that are
almost twice as much as the mean (3.5-fold) increase for the
γ-hnENaC subunit, respectively. The exact individual values
of each hnENaC subunit and each CF patient are shown in
Fig. 2 and listed in Table 3.
3.4. Protein biochemistry
In order to determine the presence and abundance of
hnENaC protein in CF and non-CF control tissue we carried
out immunoblotting experiments. SDS-PAGE analyses
showed the existence of one distinct α-hnENaC band in
the range of 66 kDa. Additionally, the anti α-ENaC antibody
detected a second distinct band in the range of 55 kDa in CF
and non-CF tissue. Before, this antibody was also tested in
Western blot experiments with proteins isolated from ENaC
expressing oocytes, where it recognised one distinct ENaC
band. Since we used protease inhibitors for the protein
purification and highly specific antibodies, the second
protein band is not due to proteolytic cleavage during the
preparation or cross-reaction of the antibody. The 66 kDa
band and the 55 kDa α-hnENaC specific fragment could
represent an endogenous proteolytic cleaved form of the α-
hnENaC protein.
The anti β-ENaC antibody bound to one specific band in
the range of 73 kDa, and with the anti γ-ENaC antibody we
identified a specific band of approximately 74 kDa. The
molecular weights of the β- and γ-hnENaC subunits were in
agreement with the calculated and previously published data
of these unprocessed proteins (http://www.ncbi.nlm.nih.
gov). For the densitometric determination we digitised the
Western blots and quantified the amount of hnENaC protein
using the ImageJ program 1.36 [32]. We found apparent
differences in the protein expression pattern between CF and
non-CF tissue. Although, we observed no detectable dif-
ferences between the 66 kDa band from CF and non-CF
tissue, the second lower α-hnENaC band was 5-fold in-
creased in CF tissue. The abundance of the CF β-hnENaC
subunit was also 3.5-fold enhanced as compared with non-
CF samples. In contrast to these observations, the quantity of
the γ-hnENaC protein was 4-fold decreased in CF epithelia
as compared with non-CF tissue. Fig. 3A shows represen-Table 3
Individual hnENaC mRNA expression level of each CF patient compared
with the non-CF control group (normalised to 1.0)
No. of CF patient α-hnENaC
(x-fold increase)
β-hnENaC
(x-fold increase)
γ-hnENaC
(x-fold increase)
CF tissue specimen 1 1.46±0.17 2.57±0.09 6.07±0.33
CF tissue specimen 2 2.50±0.28 1.86±0.13 1.34±0.03
CF tissue specimen 3 2.23±0.33 5.96±0.23 3.49±0.31
CF tissue specimen 4 1.25±0.12 2.51±0.04 3.26±0.32
CF tissue specimen 5 1.20±0.08 2.34±0.20 1.31±0.08
CF tissue specimen 6 1.38±0.09 4.70±0.51 4.99±0.40tative Western blots for all three subunits, and the densi-
tometric evaluation of the specific hnENaC bands is shown
in Fig. 3B.
4. Discussion
ENaC is involved in the airway symptoms of CF due to its
hyperactivity resulting in an accelerated Na+ absorption and
an increase in lung mucus viscosity. In respect to the changes
in the mucus of CF patients, two opposing hypothesis
concerning the ionic composition of the airway surface liquid
(ASL) are discussed: (i) the hypotonic theory (ASL/defensin
hypothesis) postulates that normal airway epithelia are
covered by an ASL with a low NaCl concentration, which
enables the inflammatory response and defence against
bacteria. (ii) The other hypothesis (the isotonic volume
transport/mucus clearance hypothesis) deals with the ion
transport functions of CFTR and links the defects in ion
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Jayaraman et al. investigated airway surface liquid height and
found no evidence for active ion transport regulating ASL
height in tracheal epithelia [36]. In contrast, in many studies it
was demonstrated that an unbalanced ion composition of the
mucus lining the airways due to malfunction of CFTR and
ENaC is responsible for the lung symptoms of CF patients
[23,35]. CF epithelia are characterised by a markedly
increased Na+ uptake via ENaC. In this study we confirm
and substantially extend previous findings from primary
cultured cells [3] demonstrating that the total transepithelial
short circuit current (Isc) across CF respiratory epithelia is
increased by about 40% while the amiloride-sensitive Na+
uptake via ENaC (Isc(amilo)) is nearly doubled in vitro. In CF
nasal epithelia Na+ absorption mediated by ENaC represents
the major part in total epithelial ion transport. Therefore, we
set out to explore the molecular mechanisms underlying that
strong Na+ hyperabsorption in CF epithelia.
There are many hypotheses dealing with the hyperactivity
of ENaC. It is possible that either the molecular structure of the
ENaC genes is modified or that the regulation or interaction
with CFTR and the channel is biased. However, due to the lack
of an appropriate mouse model reproducing the human CF
airway epithelial phenotype, it is very difficult to study the
situation in vivo. In the present study we used human nasal
tissue as a well-established cell model system [26,37] to
investigate the hnENaC in CF and non-CF epithelia in vitro.
Thus, we compared the molecular sequences of CF and non-
CF hnENaC, and investigated mRNA and protein levels of CF
and non-CF hnENaC. In a multi-sequence alignment of the six
nucleotide hnENaC sequences no differences between CF and
non-CF tissue were observed. These results indicate that the
Na+ hyperabsorption via ENaC in CF epithelia is not due to
structural modifications or mutations of the ENaC genes.
However, we found some gene polymorphisms, which have
been described previously for human ENaC derived from
other tissues. We identified a common T663A polymorphism
within the C-terminus of the hnENaC α-subunit of CF and
non-CF epithelia. Furthermore, polymorphisms in the β- and
γ-hnENaC subunits have been detected. Since all polymorph-
isms are present in both CF and non-CF hnENaC these
changes in the nucleotide sequences are not sufficient to
explain the drastic Na+ hyperabsorption in CF.
To prove the hypothesis that the increased Na+ absorption
in CF airways could be due to an enhanced expression of
hnENaC, we compared the mRNA expression levels of
hnENaC derived from non-CF and CF epithelia using qRT-
PCR. Indeed we observed an increase in the mRNA levels
of all three hnENaC subunits in CF tissue compared with
the non-CF samples. These results show for the first time a
direct correlation between cystic fibrosis and the mRNA
level of hnENaC. In this context it is obvious that mainly
the regulatory subunits of ENaC, the β- and the γ-subunit
[5], are elevated. This fact could indicate that in CF the
regulation of the ion channel itself is modified. However,
the upregulation of hnENaC might be associated with thefunctional amiloride-sensitive Na+ hyperabsorption in CF
tissue, which was shown in several studies [1,3]. The
molecular mechanisms leading to the increase in ENaC
mRNA transcription are still unknown.
By comparing hnENaC between CF and non-CF tissue at
the protein level we found remarkable differences in the
protein expression: the α- and β-ENaC subunits are in-
creased in CF tissue while the γ-ENaC subunit is decreased.
The specific anti α-ENaC antibody detected two distinct
protein bands in CF and non-CF tissue, only one being
increased in all CF samples. Previously, it was demonstrated
that ENaC undergoes extensive post-translational processing
by proteolytic cleavage and glycosylation [38,39]. This
processing may result in tissue specific protein bands with
varying molecular weights. Recently, a compilation of the
molecular weights of ENaC from different cell types and
tissues was published [40]. In addition to the increased
mRNA level the changes in protein expression of hnENaC
found in CF tissue indicate that the regulation or post-
translational processes in CF could be modified.
In the pathogenesis of CF, infections with pathogens,
inflammation, changes in protease activity or impaired reg-
ulation by defect CFTR are described [41,42]. Furthermore,
mediators of the immune response like cytokines could
influence the transcriptional processes. For example, the lack
of CFTR leads to abnormal function of transcription factors,
which regulate the synthesis of the pro-inflammatory
cytokines and chemokines elevated in CF (reviewed by
[43]). It was shown that the colonisation of the viscous mucus
lining the respiratory epithelia of CF patients with the
pathogen P. aeruginosa affects the transcription of the three
ENaC subunits and a transiently increased β-ENaC mRNA
expression [24]. Other pathogens, which colonise CF epi-
thelia in the lung like Staphyloccocus aureusmight also play
an important role in this context [44]. Thus, the chronic
infections of the CF patients could cause the changes in the
expression of ENaC. Taken together, all these factors might
modulate the regulation of hnENaC mRNA and protein
expression. However, no direct correlation between mRNA
transcription and protein level was found. In this context May
et al. showed that changes on the mRNA level might not
strictly reflect changes at the protein level and vice versa [45].
We hypothesise that the differences in the protein
expression between CF tissue and the control group could
indicate a modified hnENaC subunit composition in CF
epithelia. It was demonstrated that the expression level of each
subunit is markedly different in various Na+ absorbing
epithelia and that single channel conductances are dependent
on the subunit composition of ENaC. Furthermore, it is known
that changes in the stoichiometry of heteromultimeric proteins,
e.g. ENaC, lead to different functional properties [46]. The
expression of the three ENaC subunits seems to vary
considerably between different tissues. It was shown that
some cells in the lung express only the α- and γ-ENaC
subunits [47]. In colon and kidney the expression of the three
ENaC subunits extremely depends on the stimulation by
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immunological and electrophysiological methods very rapid
changes in the processing and maturation of the channels in rat
kidney which could be due to a daily regulation of ENaC
activity and Na+ reabsorption [50]. Therefore, it is likely that
the hnENaC subunit composition in CF tissue is indeed altered
and the physiological properties are changed. The combination
of an increase in hnENaC transcription and a modified
stoichiometry might explain Na+ hyperabsorption in CF.
Taken together, in this study we found for the first time strong
evidence that hnENaC inCF tissue ismarkedly increased at the
mRNAand protein level comparedwith non-CF samples. This
could be due to a modified hnENaC regulation resulting in
channels with modulated physiological properties and an
elevatedNa+ absorption. Since cells derived from human nasal
epithelium have been reliable and useful tools for the study of
ion transport defects related to CF in vitro [26,37], these results
are important for ongoing CF therapies. According to the
amiloride/benzamil therapy which decreased the Na+ absorp-
tion [51,52] long-lasting suppression of ENaC transcription
with highly specific antisense oligonucleotides (Weber et al.,
unpublished data) can be developed.
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